ARRDC3 and breast cancer: In the current study, we tested the hypothesis that a metastastic suppressor, ARRDC3 (arrestin domain-containing 3) is a major regulator in determining efficiency of ITG β4 recycling and its sorting into breast cancer cell-derived EVs.